Live Breaking News & Updates on கிறிஸ்டியன் ஹமாச்சர்
Stay updated with breaking news from கிறிஸ்டியன் ஹமாச்சர். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Biocon Biologics receives Rs 555 Cr (USD 75 Million) Capital Injection from ADQ Posted On: 2021-01-07 05:05:23 (Time Zone: Arizona, USA) Biocon Ltd (BSE code: 532523, NSE: BIOCON), an innovation-led global biopharmaceuticals company, today announced that the Board of its subsidiary Biocon Biologics Ltd ( Biocon Biologics ) has approved a primary equity investment by Abu Dhabi based ADQ ( ADQ ), one of the region s largest holding companies. As per the terms of the proposed agreement, ADQ will invest Rs 555 Crore for a 1.80% minority stake in the biosimilar business, valuing Biocon Biologics at a post money valuation of ~USD 4.17 billion1. The transaction is subject to customary condition precedents and approvals. Post the completion of this transaction, Biocon Ltd will hold 89.89% stake in Biocon Biologics on a fully diluted basis. ....
Tanzania: Reason to Smile for Diabetic Patients in Tanzania allafrica.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from allafrica.com Daily Mail and Mail on Sunday newspapers.
Biocon Biologics signs MoU with Tanzania for affordable access to quality insulins Biocon Biologics signs MoU with Tanzania for affordable access to quality insulins 16 December 2020 | News Biocon Biologics is helping unlock universal access to quality insulins in low- and middle-income countries (LMICs) by making recombinant human insulin (rh-insulin) available for less than $0.10 per day Source credit: Shutterstock Biocon Biologics Ltd, a fully integrated ‘pure play’ biosimilars company and a subsidiary of Biocon Ltd in continuation of its Mission 10 cents affordable insulins programme for low- and middle-income countries (LMICs), has signed a Memorandum of Understanding (MoU) with the Christian Social Services Commission (CSSC), a faith-based organisation active in Africa. CSSC works closely with the government as well as international and national partners to facilitate health and education services. Tanzania will be the first country in Africa ....
Biocon Biologics signs an MoU with CSSC in Tanzania for Mission 10 cents Posted On: 2020-12-15 07:16:06 (Time Zone: Arizona, USA) Biocon Biologics Ltd., a fully integrated pure play biosimilars company and a subsidiary of Biocon Ltd. (BSE code: 532523, NSE: BIOCON), in continuation of its Mission 10 cents affordable insulins program for low- and middle-income countries (LMICs), has signed a Memorandum of Understanding (MoU) with the Christian Social Services Commission (CSSC), a faith-based organization active in Africa. CSSC works closely with the government as well as international and national partners to facilitate health and education services. Tanzania will be the first country in Africa that will benefit from this collaboration between Biocon Biologics and CSSC. ....
Synopsis Biocon said the CHMP positive opinion will be considered by the European Commission. The European Commission decision on the approval is expected early next year. ThinkStock Photos NEW DELHI: Biotechnology firm Biocon on Monday said its subsidiary Biocon Biologics and Mylan have received a positive opinion from the European Medicines Agency s committee for medicinal products for human use (CHMP) recommending approval of the market authorisation of their product Kixelle use for the treatment of type 1 and 2 diabetes. Biocon Biologics and Mylan (a subsidiary of Viatris Inc.) have received a positive opinion from the European Medicines Agency s committee for medicinal products for human use (CHMP) recommending approval of the market authorisation of Kixelle, a biosimilar Insulin Aspart, which is a rapid acting insulin for the treatment of type 1 and 2 diabetes, Biocon said in a regulatory filing. ....